Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Mesothelioma: HELP
Nelson G. Ordoñez
Based on 24 articles published since 2007
||||
Expertise Level
The expertise of Nelson G. Ordoñez ranks in the
  • Top 0.13%
  • ... of 15,808 published authors worldwide on Mesothelioma
  • ... from 2007 through 2018
  • ... based on contributions to 24 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Ordóñez, Nelson G   ·   Ordonez, Nelson G   ·   Ordonez, Nelson   ·   Ordoñez, Nelson G
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2014
  • The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 24816068
  • Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Pubmed 23531849
2013
  • The University of Texas MD Anderson Cancer Center, Department of Pathology, Houston, TX 77030, USA. · Pubmed 22963903
  • Department of Pathology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 23596113
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23503645
  • Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23196794
  • Department of Pathology, The University of Texas, MD, Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23041828
  • Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22820661
2012
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22684220
  • Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22710819
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22388762
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22222641
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22037261
2007
  • The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA. · Pubmed 17506256
2018
  • From the Department of Pathology, University of Chicago Medical Center, Chicago, Illinois (Drs Husain and Krausz); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona (Dr Colby, emeritus); the Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston (Dr Ordóñez); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Cellular Pathology, University Hospital of Wales and Cardiff University, Cardiff, South Glamorgan, Wales (Dr Attanoos); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, University of Vermont College of Medicine, Burlington (Dr Butnor); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); Centre National Référent MESOPATH Departement de Biopathologie, Lyon Cedex, France (Dr Galateau-Sallé); the Department of Pathology, University Hospital of Wales, Penarth, South Glamorgan, Wales (Dr Gibbs); the Department of Pathology, PhenoPath Laboratories, Seattle, Washington (Dr Gown); the Department of Pathology & Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, (Dr Litzky); the Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California (Drs Marchevsky and Walts); the Department of Histopathology, Royal Brompton & Harefield National Health Service Foundation Trust and the National Heart and Lung Institute, Imperial College, Chelsea, London, England (Dr Nicholson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Department of Pathology, University of Pittsburgh, and the VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania (Dr Sharma); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Travis); and the Department of Pathology, University of Virginia Medical Center, Charlottesville (Dr Wick). · Pubmed 28686500
2014
  • *Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada †Department of Pathology, The University of Texas Medical Branch Galveston §Department of Pathology and Genomic Medicine, Houston Methodist Hospital **Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX ‡Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY ¶PhenoPath Laboratories, Seattle, WA ††Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale, AZ ‡‡Department of Pathology, University of Virginia Health System, Charlottesville, VA ∥Department of Pathology, CHU Caen, Caen, France #Department of Clinical Pathology, Ospedale dell'Angelo Venezia, Mestre, Italy. · Pubmed 24618613
2007
  • Department of Thoracic/Head and Neck Medical Oncology, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 432, Houston, TX 77030, USA. · Pubmed 17620427
  • Phase I Program, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 17602922
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 24 total) written by Nelson G. Ordoñez about Mesothelioma:

  • Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. 2018
  • Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study. 2014
  • Well-differentiated papillary mesothelioma with invasive foci. 2014
  • Value of podoplanin as an immunohistochemical marker in tumor diagnosis: a review and update. 2014
  • Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. 2013
  • Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update. 2013
  • Value of claudin-4 immunostaining in the diagnosis of mesothelioma. 2013
  • Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma. 2013
  • Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas. 2013
  • Mesothelioma with signet-ring cell features: report of 23 cases. 2013
Show List of Full Article Records
Google Searches

Learn more about Nelson G. Ordoñez using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2014
  • The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 24816068
  • Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Pubmed 23531849
2013
  • The University of Texas MD Anderson Cancer Center, Department of Pathology, Houston, TX 77030, USA. · Pubmed 22963903
  • Department of Pathology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 23596113
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23503645
  • Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23196794
  • Department of Pathology, The University of Texas, MD, Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23041828
  • Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22820661
2012
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22684220
  • Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22710819
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22388762
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22222641
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22037261
2007
  • The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA. · Pubmed 17506256
2018
  • From the Department of Pathology, University of Chicago Medical Center, Chicago, Illinois (Drs Husain and Krausz); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona (Dr Colby, emeritus); the Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston (Dr Ordóñez); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Cellular Pathology, University Hospital of Wales and Cardiff University, Cardiff, South Glamorgan, Wales (Dr Attanoos); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, University of Vermont College of Medicine, Burlington (Dr Butnor); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); Centre National Référent MESOPATH Departement de Biopathologie, Lyon Cedex, France (Dr Galateau-Sallé); the Department of Pathology, University Hospital of Wales, Penarth, South Glamorgan, Wales (Dr Gibbs); the Department of Pathology, PhenoPath Laboratories, Seattle, Washington (Dr Gown); the Department of Pathology & Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, (Dr Litzky); the Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California (Drs Marchevsky and Walts); the Department of Histopathology, Royal Brompton & Harefield National Health Service Foundation Trust and the National Heart and Lung Institute, Imperial College, Chelsea, London, England (Dr Nicholson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Department of Pathology, University of Pittsburgh, and the VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania (Dr Sharma); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Travis); and the Department of Pathology, University of Virginia Medical Center, Charlottesville (Dr Wick). · Pubmed 28686500
2014
  • *Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada †Department of Pathology, The University of Texas Medical Branch Galveston §Department of Pathology and Genomic Medicine, Houston Methodist Hospital **Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX ‡Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY ¶PhenoPath Laboratories, Seattle, WA ††Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale, AZ ‡‡Department of Pathology, University of Virginia Health System, Charlottesville, VA ∥Department of Pathology, CHU Caen, Caen, France #Department of Clinical Pathology, Ospedale dell'Angelo Venezia, Mestre, Italy. · Pubmed 24618613
2007
  • Department of Thoracic/Head and Neck Medical Oncology, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 432, Houston, TX 77030, USA. · Pubmed 17620427
  • Phase I Program, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 17602922
31 Other Locations Show
Yearly article counts 100037510115
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.